by Igen BioLab Group | Feb 25, 2020 | News
Checkpoint inhibitors have revolutionized cancer therapy but only work in a subset of patients and can lead to a multitude of toxicities, suggesting the need for more targeted delivery systems. Because of their preferential colonization of tumors, microbes are a...
by Igen BioLab Group | Jan 7, 2020 | News
The human microbiome has not only captured the attention of scientists, but also of health professionals and the lay press. Although initial studies focused on characterizing the intestinal microbiome in the context of health and disease and the influence of...
by Igen BioLab Group | Dec 30, 2019 | News
The mucus layer in the human colon protects against commensal bacteria and pathogens, and defects in its unique bilayered structure contribute to intestinal disorders, such as ulcerative colitis. However, our understanding of colon physiology is limited by the lack of...
by Igen BioLab Group | Dec 20, 2019 | News
Implications for pathogenesis, diagnosis, and therapy Colorectal cancer (CRC) is one of the most frequently diagnosed cancers and leading cause of cancer-related deaths worldwide. In recent years, there has been a growing realization that lifestyle plays a major role...
by Igen BioLab Group | Nov 25, 2019 | News
The gastroenterology team at Henri-Mondor AP-HP Hospital and University Paris-Est Créteil, led by Professor Iradj Sobhani, together with teams from Inserm and the Institut Pasteur Molecular Microbial Pathogenesis Unit (U1202), led by Professor Philippe Sansonetti...
